# Immunovant, Inc.: Form 4, filed Aug 2, 2021

- Company: [Immunovant, Inc.](/companies/imvt.md) (CIK 1764013)
- Form: 4
- Filed: 2021-08-02
- Accepted by EDGAR: Aug 2, 2021, 21:46 ET
- Period: 2021-08-02
- Accession: 0001104659-21-099083
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1764013/000110465921099083/xslF345X03/tm2123817-2_4seq1.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1764013/000110465921099083/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1764013/000110465921099083/xslF345X03/tm2123817-2_4seq1.xml

Filed Aug 2, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-099083. Last ingested by Listed: Nov 9, 2026, 17:43 ET. No prices; not investment advice.